Sofinnova Investments’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Sofinnova Investments’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,162,176	Closed	-$3.87M	–	77
2019 Q4	$3.87M	Sell	1,162,176 -37,078	-3%	-$118K	0.28%	48
2019 Q3	$3.65M	Buy	1,199,254 +83,444	+7%	+$235K	0.33%	47
2019 Q2	$2.65M	Buy	1,115,810 +283,517	+34%	+$847K	0.24%	49
2019 Q1	$3.12M	Hold	832,293	–	–	0.3%	50
2018 Q4	$2.99M	Buy	832,293 +163,674	+24%	+$712K	0.37%	46
2018 Q3	$3.83M	Sell	668,619 -13,780	-2%	-$78.8K	0.34%	43
2018 Q2	$3.42M	Buy	682,399 +610,382	+848%	+$3.14M	0.39%	43
2018 Q1	$369K	Buy	+72,017	New	+$433K	0.06%	37

Sofinnova Investments's FOMX Position: Q1 2020 in Review

Sofinnova Investments sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 1,162,176 shares — an estimated $3.87M sold.

Sofinnova Investments first reported a position in FOMX in Q1 2018 and held it in 8 quarters. The position peaked at $3.87M in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Sofinnova Investments reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Sofinnova Investments sold 1,162,176 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $3.87M.
Sofinnova Investments first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2018 and held it in 8 quarters.
Sofinnova Investments's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $3.87M in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Sofinnova Investments's 13F filing for Q1 2020, filed 13 May 2020.